Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 6.989E-06 | 7.247E-03 | CA2, CA7 |
BP | GO:0065007; biological regulation | GO:0006919; activation of cysteine-type endopeptidase activity involved in apoptotic process | 7.600E-06 | 7.522E-03 | CASP1, CASP7, MAPT, XDH |
BP | GO:0065007; biological regulation | GO:0010817; regulation of hormone levels | 1.018E-05 | 9.639E-03 | ACHE, ADRA2A, ADRA2C, ALDH1A1, HIF1A, NR1H4, SLCO1B1 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 9.519E-18 | 8.553E-14 | CA1, CA12, CA13, CA14, CA2, CA4, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 3.587E-16 | 1.562E-12 | CA1, CA12, CA13, CA2, CA4, CA6, CA7, CA9 |
CC | GO:0016020; membrane | GO:0016323; basolateral plasma membrane | 1.157E-08 | 2.100E-05 | ADRA2A, CA2, CA4, CA9, HPGD, SLCO1B1, SLCO1B3 |
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 2.556E-06 | 3.092E-03 | CA1, CA12, CA13, CA2, CA4, CA6, CA7, CA9, NR1H4 |
MF | GO:0060089; molecular transducer activity | GO:0004938; alpha2-adrenergic receptor activity | 6.989E-06 | 7.247E-03 | ADRA2A, ADRA2C |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 6.914E-23 | 1.506E-18 | CA1, CA12, CA13, CA14, CA2, CA4, CA6, CA7, CA9 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00232 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.169E-05 | 8.531E-04 | CYP1A2; XDH |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 8.611E-04 | 1.452E-02 | CYP1A2; ALOX15 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 4.266E-03 | 3.815E-02 | CYP1A2; ALDH1A1 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.451E-22 | 2.892E-20 | CA12; CA1; CA2; CA4; CA7; CA6; CA9; CA14; CA13 |
hsa04022 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.967E-03 | 2.901E-02 | MAPK1; ADRA2C; ADRA2A |
hsa04150 | mTOR signaling pathway_Homo sapiens_hsa04150 | 3.647E-03 | 3.815E-02 | MAPK1; HIF1A |
hsa04621 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 3.298E-03 | 3.815E-02 | CASP1; MAPK1 |
hsa04964 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 5.396E-04 | 1.061E-02 | CA2; CA4 |
hsa04976 | Bile secretion_Homo sapiens_hsa04976 | 3.726E-06 | 2.198E-04 | SLCO1B1; CA2; SLCO1B3; NR1H4 |
hsa05010 | Alzheimer's disease_Homo sapiens_hsa05010 | 1.110E-04 | 3.275E-03 | CASP7; MAPK1; MAPT; HSD17B10 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE |
C00-D49: Neoplasms | Solid tumours | C00-D48 | HIF1A; CA9; MAPK1 |
C00-D49: Neoplasms | Cancer | C00-C96 | HIF1A; CA1; CA9; MAPK1; ACHE |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
C00-D49: Neoplasms | Breast cancer | C50 | CA9 |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | HIF1A; CA9 |
E00-E89: Endocrine, nutritional and metabolic diseases | Pompe's disease | E74.02 | GAA |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic nephropathy | E11.21 | ADRA2C |